These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effects of TAK-875, a selective G protein-coupled receptor 40/free fatty acid 1 agonist, on insulin and glucagon secretion in isolated rat and human islets. Yashiro H; Tsujihata Y; Takeuchi K; Hazama M; Johnson PR; Rorsman P J Pharmacol Exp Ther; 2012 Feb; 340(2):483-9. PubMed ID: 22106100 [TBL] [Abstract][Full Text] [Related]
5. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40. Schnell S; Schaefer M; Schöfl C Mol Cell Endocrinol; 2007 Jan; 263(1-2):173-80. PubMed ID: 17101212 [TBL] [Abstract][Full Text] [Related]
6. Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets. Alquier T; Peyot ML; Latour MG; Kebede M; Sorensen CM; Gesta S; Ronald Kahn C; Smith RD; Jetton TL; Metz TO; Prentki M; Poitout V Diabetes; 2009 Nov; 58(11):2607-15. PubMed ID: 19720802 [TBL] [Abstract][Full Text] [Related]
7. Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release. Fujiwara K; Maekawa F; Yada T Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E670-7. PubMed ID: 15914509 [TBL] [Abstract][Full Text] [Related]
8. GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo. Latour MG; Alquier T; Oseid E; Tremblay C; Jetton TL; Luo J; Lin DC; Poitout V Diabetes; 2007 Apr; 56(4):1087-94. PubMed ID: 17395749 [TBL] [Abstract][Full Text] [Related]
9. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells. Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643 [TBL] [Abstract][Full Text] [Related]
10. G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids. Del Guerra S; Bugliani M; D'Aleo V; Del Prato S; Boggi U; Mosca F; Filipponi F; Lupi R Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):22-5. PubMed ID: 19758793 [TBL] [Abstract][Full Text] [Related]
11. Short chain fatty acids stimulate insulin secretion and reduce apoptosis in mouse and human islets in vitro: Role of free fatty acid receptor 2. Pingitore A; Gonzalez-Abuin N; Ruz-Maldonado I; Huang GC; Frost G; Persaud SJ Diabetes Obes Metab; 2019 Feb; 21(2):330-339. PubMed ID: 30203438 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells. Yamada H; Yoshida M; Ito K; Dezaki K; Yada T; Ishikawa SE; Kakei M Sci Rep; 2016 May; 6():25912. PubMed ID: 27180622 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists. Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371 [TBL] [Abstract][Full Text] [Related]
14. GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats. Meidute Abaraviciene S; Muhammed SJ; Amisten S; Lundquist I; Salehi A Mol Cell Endocrinol; 2013 Dec; 381(1-2):150-9. PubMed ID: 23911664 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cholinergic potentiation of insulin secretion from pancreatic islets by chronic elevation of glucose and fatty acids: Protection by casein kinase 2 inhibitor. Doliba NM; Liu Q; Li C; Chen P; Liu C; Naji A; Matschinsky FM Mol Metab; 2017 Oct; 6(10):1240-1253. PubMed ID: 29031723 [TBL] [Abstract][Full Text] [Related]
17. Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion. El-Azzouny M; Evans CR; Treutelaar MK; Kennedy RT; Burant CF J Biol Chem; 2014 May; 289(19):13575-88. PubMed ID: 24675078 [TBL] [Abstract][Full Text] [Related]
18. Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice. Tan CP; Feng Y; Zhou YP; Eiermann GJ; Petrov A; Zhou C; Lin S; Salituro G; Meinke P; Mosley R; Akiyama TE; Einstein M; Kumar S; Berger JP; Mills SG; Thornberry NA; Yang L; Howard AD Diabetes; 2008 Aug; 57(8):2211-9. PubMed ID: 18477808 [TBL] [Abstract][Full Text] [Related]
19. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance. Sabrautzki S; Kaiser G; Przemeck GKH; Gerst F; Lorza-Gil E; Panse M; Sartorius T; Hoene M; Marschall S; Häring HU; Hrabě de Angelis M; Ullrich S Mol Metab; 2017 Oct; 6(10):1304-1312. PubMed ID: 29031729 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Briscoe CP; Peat AJ; McKeown SC; Corbett DF; Goetz AS; Littleton TR; McCoy DC; Kenakin TP; Andrews JL; Ammala C; Fornwald JA; Ignar DM; Jenkinson S Br J Pharmacol; 2006 Jul; 148(5):619-28. PubMed ID: 16702987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]